Objective To develop new classification criteria for systemic lupus erythematosus (SLE)
jointly supported by the European League Against Rheumatism (EULAR) and the American …

Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic
manifestations, which may or may not be associated with the development of systemic …

Abstract Objective The Systemic Lupus International Collaborating Clinics (SLICC) group
revised and validated the American College of Rheumatology (ACR) systemic lupus …

Lupus erythematosus (LE) is an inflammatory connective tissue disease of generalized
autoimmunity characterized by pathogenic autoantibodies and immune complexes …

The assessment of disease activity in systemic lupus erythematosus (SLE) is a task faced by
clinicians in every day care, but it is also required for clinical research and in randomised …

The initial appearance of subacute cutaneous lupus erythematosus (SCLE) skin lesions in
conjunction with Ro/SS‐A autoantibodies occurring as an adverse reaction to …

The skin is the second most frequently affected organ system in lupus erythematosus.
Although only very rarely life threatening—an example is lupus erythematosus-associated …

The EULAR/ACR 2019 classification criteria for SLE constitute a current and optimized
clinical approach to SLE classification. Classification is still not based on molecular …

Lupus erythematosus (LE) is a chronic, autoimmune, multisystem disease that displays
many diverse symptoms in which localized cutaneous LE (CLE) is on one end of the …

In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory
characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set …